通过新生儿免疫缺陷查提高结核疫苗接种安全性
Gregor Nosan1, Andreja Cerkvenik Škafar2
1Department of Neonatology, Division of Paediatrics, University Medical Centre Ljubljana, Bohoričeva ulica 20, 1000 Ljubljana, Slovenia; Department of Paediatrics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
Vaccine
|September 4, 2025
概括
斯洛文尼亚现在在给新生儿注射Bacillus Calmette-Guérin (BCG) 疫苗之前对新生儿进行免疫缺陷查,提高了结核病 (TB) 预防的安全性. 这种精确的方法可以保护脆弱的婴儿,同时确保及时的结核病防治.
科学领域:
- 免疫学和传染病
- 疫苗学
- 公共卫生政策
背景情况:
- 结核病 (TB) 仍然是一个重要的全球卫生问题,每年有数百万个新病例,以及多种耐药菌株的挑战.
- 对于预防婴儿结核病的严重形式来说,Bacillus Calmette-Guérin (BCG) 疫苗接种至关重要,但对免疫力低下的新生儿有风险.
- 在BCG疫苗接种之前,先天性免疫错误 (IEI) 查至关重要,以减轻易受感染的婴儿的传播感染风险.
研究的目的:
- 描述斯洛文尼亚在新生儿免疫缺陷 (IEI) 查与新生儿Bacillus Calmette-Guérin (BCG) 疫苗接种方面的创新方法.
- 突出精确的疫苗接种策略,在低发病率环境中平衡及时防治结核病 (TB) 和婴儿安全.
- 为其他低发病率国家提供一个模型,以现代化结核病预防方案.
主要方法:
- 从2024年开始实施全民新生儿免疫缺陷查 (IEI).
- 修订2025年新生儿BCG疫苗接种方案,要求在接种疫苗之前进行IEI查.
- 血液采样的具体时间 (≥48小时),结果可用性 (第5至7天) 和BCG施用 (7至14天).
主要成果:
- 通过在BCG注射之前识别免疫缺陷的新生儿,制定修订的新生儿疫苗接种方案,优先考虑婴儿安全.
- 将实时免疫遗传数据成功整合到针对性的BCG疫苗接种策略中.
- 在低发病率国家展示精确疫苗接种的可行模型.
结论:
- 斯洛文尼亚的综合IEI查和BCG疫苗接种方案提供了一种安全有效的新生儿结核病预防方法.
- 这一精确的疫苗接种策略与全球加强结核病控制和保护脆弱群体的努力相一致.
- 斯洛文尼亚模式为其他低发病率国家提供了一个有价值的框架,旨在优化其疫苗接种计划.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.7K
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
13.9K
相关概念视频
01:26Pulmonary Tuberculosis IV
196
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
196
01:28Pulmonary Tuberculosis V
236
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
236
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:28Pulmonary Tuberculosis II
339
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
339
01:31Pulmonary Tuberculosis III
438
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
438
01:25Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K